Literature DB >> 24524823

ALK-rearranged adenosquamous lung cancer presenting as squamous cell carcinoma: a potential challenge to histologic type triaging of NSCLC biopsies for molecular studies.

Konstantin H Dragnev1, Gerald Gehr2, Vincent A Memoli3, Laura J Tafe4.   

Abstract

Entities:  

Keywords:  ALK FISH; ALK rearrangement; Adenosquamous carcinoma; Molecular testing; Non–small-cell lung cancer

Mesh：

Substances：

Year:  2014        PMID： 24524823     DOI： 10.1016/j.cllc.2014.01.003

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  9 in total

1.  Surgical specimen histology revealed inadequacy of conventional transbronchial needle aspiration sample in the diagnosis of adenosquamous lung carcinoma.

Authors:  Jing Chen; Ya-Dong Gao; Yan Cao; Jiong Yang; Guang-Wei Luo
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

2.  Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib.

Authors:  Todd Hembrough; Wei-Li Liao; Christopher P Hartley; Patrick C Ma; Vamsidhar Velcheti; Christopher Lanigan; Sheeno Thyparambil; Eunkyung An; Manish Monga; David Krizman; Jon Burrows; Laura J Tafe
Journal:  Clin Chem       Date:  2015-11-19       Impact factor: 8.327

Review 3.  Molecular biomarker testing for non-small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group.

Authors:  Sunhee Chang; Hyo Sup Shim; Tae Jung Kim; Yoon-La Choi; Wan Seop Kim; Dong Hoon Shin; Lucia Kim; Heae Surng Park; Geon Kook Lee; Chang Hun Lee
Journal:  J Pathol Transl Med       Date:  2021-05-11

4.  Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.

Authors:  Jiandong Wang; Qin Shen; Qunli Shi; Bo Yu; Xuan Wang; Kai Cheng; Guangming Lu; Xiaojun Zhou
Journal:  J Exp Clin Cancer Res       Date:  2014-12-21

5.  Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review.

Authors:  Junko Watanabe; Shinsaku Togo; Issei Sumiyoshi; Yukiko Namba; Kentaro Suina; Takafumi Mizuno; Kotaro Kadoya; Hiroaki Motomura; Moe Iwai; Tetsutaro Nagaoka; Shinichi Sasaki; Takuo Hayashi; Toshimasa Uekusa; Kanae Abe; Yasuo Urata; Fuminori Sakurai; Hiroyuki Mizuguchi; Shunsuke Kato; Kazuhisa Takahashi
Journal:  Oncotarget       Date:  2018-05-08

6.  Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases.

Authors:  Anna Scattone; Annamaria Catino; Laura Schirosi; Lucia Caldarola; Stefania Tommasi; Rosanna Lacalamita; Elisabetta Sara Montagna; Domenico Galetta; Gabriella Serio; Francesco Alfredo Zito; Anita Mangia
Journal:  Transl Oncol       Date:  2018-12-04       Impact factor: 4.243

7.  Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma.

Authors:  Chao Zhang; Haitang Yang; Baoping Lang; Xiangdong Yu; Peng Xiao; Dian Zhang; Liwen Fan; Xiao Zhang
Journal:  Cancer Manag Res       Date:  2018-08-02       Impact factor: 3.989

8.  Response to crizotinib in a squamous cell lung carcinoma patient harbouring echinoderm microtubule-associated protein-like 4-anaplastic lymphoma translocation: A case report.

Authors:  Wenxian Wang; Zhengbo Song; Yiping Zhang
Journal:  Thorac Cancer       Date:  2015-07-29       Impact factor: 3.500

9.  Histological and molecular plasticity of ALK-positive non-small-cell lung cancer under targeted therapy: a case report.

Authors:  Markus Ball; Petros Christopoulos; Martina Kirchner; Michael Allgäuer; Regine Brandt; Hauke Winter; Claus Peter Heußel; Felix Herth; Stefan Fröhling; Rajkumar Savai; Mark Kriegsmann; Peter Schirmacher; Solange Peters; Michael Thomas; Albrecht Stenzinger; Daniel Kazdal
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.